Kangstem Biotech Co., Ltd. (KOSDAQ: 217730)
1,408.00
-2.00 (-0.14%)
Sep 11, 2024, 3:13 PM KST
Kangstem Biotech Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2016 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2016 |
Net Income | -9,765 | -21,949 | -20,236 | -21,348 | -18,471 | -24,635 | Upgrade
|
Depreciation & Amortization | 3,736 | 3,915 | 3,871 | 3,874 | 2,994 | 2,097 | Upgrade
|
Loss (Gain) From Sale of Assets | -10,014 | -95.52 | 5.6 | -1,272 | 19.19 | - | Upgrade
|
Asset Writedown & Restructuring Costs | 250.52 | 250.52 | - | - | 1,752 | 4,707 | Upgrade
|
Loss (Gain) From Sale of Investments | 782.87 | 151.81 | 308.46 | 348.21 | -298 | -2,022 | Upgrade
|
Loss (Gain) on Equity Investments | 660.13 | 720.33 | - | - | - | 563.07 | Upgrade
|
Stock-Based Compensation | - | 274.36 | 1,059 | 862.04 | -104.44 | 123.16 | Upgrade
|
Provision & Write-off of Bad Debts | -263.03 | -263.03 | -144.01 | -192.74 | -229.55 | 877.15 | Upgrade
|
Other Operating Activities | -426.16 | -505 | -124.4 | 348.05 | -1,499 | -1,409 | Upgrade
|
Change in Accounts Receivable | -279.56 | 1,109 | -198.26 | -371.57 | -74.22 | 939.07 | Upgrade
|
Change in Inventory | 213.19 | -68.88 | 334.59 | -534.59 | 153.96 | 883.06 | Upgrade
|
Change in Accounts Payable | 1,366 | -10.33 | -443.81 | 464.96 | -241.4 | -1,170 | Upgrade
|
Change in Other Net Operating Assets | -2,042 | -27.07 | -3,296 | 828.26 | 2,005 | 5,725 | Upgrade
|
Operating Cash Flow | -15,780 | -16,498 | -18,864 | -16,994 | -13,994 | -13,322 | Upgrade
|
Capital Expenditures | -1,449 | -1,392 | -712.42 | -4,631 | -3,038 | -15,342 | Upgrade
|
Sale of Property, Plant & Equipment | 101 | 28 | 19.36 | 2.27 | 46.61 | - | Upgrade
|
Sale (Purchase) of Intangibles | 559.09 | 542.2 | -135.06 | -19.42 | -15.59 | -1,723 | Upgrade
|
Investment in Securities | -6,490 | -1,496 | 17,103 | -22,955 | 32,839 | -21,200 | Upgrade
|
Other Investing Activities | 114.18 | 13.66 | -39.02 | 2,828 | 17.06 | 134.9 | Upgrade
|
Investing Cash Flow | -6,345 | -2,304 | 16,236 | -24,775 | 29,849 | -38,131 | Upgrade
|
Long-Term Debt Issued | - | 380 | 1,100 | 1,830 | - | 5,400 | Upgrade
|
Total Debt Issued | 1,880 | 380 | 1,100 | 1,830 | - | 5,400 | Upgrade
|
Long-Term Debt Repaid | - | -923.48 | -1,568 | -918.89 | -13,298 | -2,170 | Upgrade
|
Total Debt Repaid | -689.71 | -923.48 | -1,568 | -918.89 | -13,298 | -2,170 | Upgrade
|
Net Debt Issued (Repaid) | 1,190 | -543.48 | -468.3 | 911.11 | -13,298 | 3,230 | Upgrade
|
Issuance of Common Stock | 20,521 | 20,521 | 236.7 | 38,377 | 193.55 | 47,779 | Upgrade
|
Other Financing Activities | 0.1 | -0 | 0.21 | -2.4 | -462.87 | 2.27 | Upgrade
|
Financing Cash Flow | 21,710 | 19,977 | -231.4 | 39,286 | -13,567 | 55,911 | Upgrade
|
Foreign Exchange Rate Adjustments | 0.16 | 0.07 | -1.33 | 55.47 | - | - | Upgrade
|
Miscellaneous Cash Flow Adjustments | -0 | - | - | -0 | 0 | 0 | Upgrade
|
Net Cash Flow | -414.22 | 1,175 | -2,861 | -2,427 | 2,288 | 4,459 | Upgrade
|
Free Cash Flow | -17,229 | -17,890 | -19,576 | -21,624 | -17,033 | -28,664 | Upgrade
|
Free Cash Flow Margin | -129.76% | -140.82% | -120.10% | -174.32% | -186.39% | -477.37% | Upgrade
|
Free Cash Flow Per Share | -344.42 | -440.63 | -516.01 | -776.52 | -763.89 | -1375.45 | Upgrade
|
Cash Interest Paid | 523.78 | 567.02 | 364 | 211.46 | 248.5 | 239.8 | Upgrade
|
Cash Income Tax Paid | 0.42 | 73.02 | 73.21 | -65.94 | 5.67 | 135.84 | Upgrade
|
Levered Free Cash Flow | -10,255 | -9,991 | -13,595 | -15,281 | -10,731 | -25,257 | Upgrade
|
Unlevered Free Cash Flow | -9,707 | -9,432 | -13,119 | -14,806 | -10,380 | -24,584 | Upgrade
|
Change in Net Working Capital | -437.89 | -1,614 | 3,792 | 193.39 | -1,492 | -4,747 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.